FABTECHFabtech Technologies Limited
Healthcare · Health Information Services · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on FABTECH — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 35/100)
- • Profit growth: -17.4% YoY
- • ROE: 9.1%
- • Price vs EMA21: below
- • Price vs SMA50: below
Bull case
- • Debt/Equity: 0.17
- • Promoter holding: 72.0%
- • Valuation vs sector: P/E 13.4 vs sector 52.7
- • MACD: bullish
Bear case
- • Profit growth: -17.4% YoY
- • ROE: 9.1%
- • Price vs EMA21: below
- • Price vs SMA50: below
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Momentum is fading versus the broader market
- • Profit growth: -17.4% YoY
- • ROE: 9.1%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹4.37). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.